14-3-3σ and Its Modulators in Cancer
14-3-3σ is an acidic homodimer protein with more than one hundred different protein partners associated with oncogenic signaling and cell cycle regulation. This review aims to highlight the crucial role of 14-3-3σ in controlling tumor growth and apoptosis and provide a detailed discussion on the str...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/13/12/441 |
id |
doaj-e95310b31dc648118435c7006dfe02ea |
---|---|
record_format |
Article |
spelling |
doaj-e95310b31dc648118435c7006dfe02ea2020-12-04T00:02:36ZengMDPI AGPharmaceuticals1424-82472020-12-011344144110.3390/ph1312044114-3-3σ and Its Modulators in CancerGhazi Aljabal0Beow Keat Yap1School of Pharmaceutical Sciences, Universiti Sains Malaysia, Gelugor 11800, Penang, MalaysiaSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, Gelugor 11800, Penang, Malaysia14-3-3σ is an acidic homodimer protein with more than one hundred different protein partners associated with oncogenic signaling and cell cycle regulation. This review aims to highlight the crucial role of 14-3-3σ in controlling tumor growth and apoptosis and provide a detailed discussion on the structure–activity relationship and binding interactions of the most recent 14-3-3σ protein-protein interaction (PPI) modulators reported to date, which has not been reviewed previously. This includes the new fusicoccanes stabilizers (FC-NAc, DP-005), fragment stabilizers (TCF521-123, TCF521-129, AZ-003, AZ-008), phosphate-based inhibitors (IMP, PLP), peptide inhibitors (2a–d), as well as inhibitors from natural sources (85531185, 95911592). Additionally, this review will also include the discussions of the recent efforts by a different group of researchers for understanding the binding mechanisms of existing 14-3-3σ PPI modulators. The strategies and state-of-the-art techniques applied by various group of researchers in the discovery of a different chemical class of 14-3-3σ modulators for cancer are also briefly discussed in this review, which can be used as a guide in the development of new 14-3-3σ modulators in the near future.https://www.mdpi.com/1424-8247/13/12/441protein-protein interaction (PPI)14-3-3σdimerstabilizerinhibitorcancer |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ghazi Aljabal Beow Keat Yap |
spellingShingle |
Ghazi Aljabal Beow Keat Yap 14-3-3σ and Its Modulators in Cancer Pharmaceuticals protein-protein interaction (PPI) 14-3-3σ dimer stabilizer inhibitor cancer |
author_facet |
Ghazi Aljabal Beow Keat Yap |
author_sort |
Ghazi Aljabal |
title |
14-3-3σ and Its Modulators in Cancer |
title_short |
14-3-3σ and Its Modulators in Cancer |
title_full |
14-3-3σ and Its Modulators in Cancer |
title_fullStr |
14-3-3σ and Its Modulators in Cancer |
title_full_unstemmed |
14-3-3σ and Its Modulators in Cancer |
title_sort |
14-3-3σ and its modulators in cancer |
publisher |
MDPI AG |
series |
Pharmaceuticals |
issn |
1424-8247 |
publishDate |
2020-12-01 |
description |
14-3-3σ is an acidic homodimer protein with more than one hundred different protein partners associated with oncogenic signaling and cell cycle regulation. This review aims to highlight the crucial role of 14-3-3σ in controlling tumor growth and apoptosis and provide a detailed discussion on the structure–activity relationship and binding interactions of the most recent 14-3-3σ protein-protein interaction (PPI) modulators reported to date, which has not been reviewed previously. This includes the new fusicoccanes stabilizers (FC-NAc, DP-005), fragment stabilizers (TCF521-123, TCF521-129, AZ-003, AZ-008), phosphate-based inhibitors (IMP, PLP), peptide inhibitors (2a–d), as well as inhibitors from natural sources (85531185, 95911592). Additionally, this review will also include the discussions of the recent efforts by a different group of researchers for understanding the binding mechanisms of existing 14-3-3σ PPI modulators. The strategies and state-of-the-art techniques applied by various group of researchers in the discovery of a different chemical class of 14-3-3σ modulators for cancer are also briefly discussed in this review, which can be used as a guide in the development of new 14-3-3σ modulators in the near future. |
topic |
protein-protein interaction (PPI) 14-3-3σ dimer stabilizer inhibitor cancer |
url |
https://www.mdpi.com/1424-8247/13/12/441 |
work_keys_str_mv |
AT ghazialjabal 1433sanditsmodulatorsincancer AT beowkeatyap 1433sanditsmodulatorsincancer |
_version_ |
1724401055558533120 |